Skip to main content

Peer Review reports

From: Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine

Original Submission
15 Apr 2014 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
11 Jun 2015 Editorially accepted
3 Jul 2015 Article published 10.1186/s12883-015-0353-x

You can find further information about peer review here.

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us